(Q37855779)

24 August 2017

1 reference

title

The role of antipsychotics in smoking and smoking cessation (English)

1 reference

24 August 2017

Suzanne H Mitchell

3

0 references

author name string

Annette M Matthews

series ordinal

1

1 reference

24 August 2017

Vanessa B Wilson

series ordinal

2

1 reference

24 August 2017

publication date

1 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

25

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

299-315

1 reference

Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Nicotine intake in smokers increases following a single dose of haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Does clozapine decrease smoking?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Predictors of early abstinence in smokers with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Predictors of abstinence and changes in psychiatric symptoms in a pooled sample of smokers with schizophrenia receiving combination pharmacotherapy and behavioral therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Concomitant clozapine reduces smoking in patients treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Clozapine and body mass change.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Modulating tobacco smoking rates by dopaminergic stimulation and blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Nicotine replacement therapy-associated syndrome of inappropriate antidiuretic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Association analysis between the C-1291G polymorphism in the promoter region of the adrenergic alpha2A receptor gene and polydipsia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Relationship of Tridimensional Personality Questionnaire scores and smoking variables in female and male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Stimulant-induced changes in smoking and caloric intake: influence of rate of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

A placebo-controlled trial of modafinil for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

The relevance and treatment of cue-induced cravings in tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Effects of haloperidol on reactions to smoking cues in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Trauma exposure influences cue elicited affective responses among smokers with and without a history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Economic theory and evidence on smoking behavior of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Macro-social influences: the effects of prices and tobacco-control policies on the demand for tobacco products

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Effects of response requirement and the availability of an alternative reinforcer on cigarette smoking by schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Do patients with schizophrenia exhibit aberrant salience?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

A 51-year-old woman with bipolar disorder who wants to quit smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588170-000000000-00000

Double-blind study of clozapine dose response in chronic schizophrenia

21 January 2018

1 reference

12 December 2020

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

12 December 2020

The effects of dopaminergic D2 stimulation and blockade on smoking behavior

1 reference

12 December 2020

Effects of clozapine on smoking in chronic schizophrenic outpatients

1 reference

12 December 2020

Adolescent smoking and depression: which comes first?

1 reference

12 December 2020

Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?

1 reference

12 December 2020

Does clozapine affect smoking rates?

1 reference

12 December 2020

Haloperidol increases smoking in patients with schizophrenia

1 reference

12 December 2020

Metabolic considerations in the use of antipsychotic medications: a review of recent evidence

1 reference

12 December 2020

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia

1 reference

12 December 2020

Smoking and therapeutic response to clozapine in patients with schizophrenia

1 reference

12 December 2020

Olanzapine attenuates cue-elicited craving for tobacco

1 reference

12 December 2020

Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders

1 reference

12 December 2020

The expanding indications for clozapine

1 reference

12 December 2020

Smoking withdrawal symptoms in two weeks of abstinence

1 reference

12 December 2020

Smoking and mental illness: A population-based prevalence study

1 reference

12 December 2020

A pharmacological analysis of stimulant-induced increases in smoking

1 reference

12 December 2020

Reduction of comorbid substance abuse with clozapine

1 reference

12 December 2020

The $5 man: the underground economic response to a large cigarette tax increase in New York City

1 reference

12 December 2020

Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence

1 reference

12 December 2020

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

12 December 2020

10.2165/11588170-000000000-00000

Identifiers

DOI

1 reference

24 August 2017

1 reference